PAIRNOMIX

Pairnomix launched in January of 2016 to empower physicians and patients who want to know more about rare genetic mutations and new uses for drugs that could be prescribed to help the patient today. As a personalized genetic research company, the Pairnomix process involves creating a model of a patient’s genetic mutation, learning about the functional consequences of that mutation, and testing approved drugs against the model to discover new treatment options. Findings are delivered in customized reports to the patient’s physician so together patient and physician can make better-informed healthcare decisions. Additionally, we use the learnings to support rare disease drug discovery and development efforts.